TrialThe Lancet. Respiratory medicine2021

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.

Phillip D Monk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.